Furthermore, to find out whether our synthesized compounds can cause inhibition of any target to combat COVID-19, though virtually only, we considered the main protease (Mpro) or chymotrypsin-like protease (3CLpro) as a potential drug target in COVID-19, which is highly conservable among coronaviruses42. This evidence concerns the gene CTRL and COVID-19.